Total Funding
55
Total FundingSeries D raised
Growth Score in past quarter
pts
Heat Score 55 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2051121
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics.
- Michael R. Bristow: Founder
About the Company
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics
provide us with the capability to discover novel therapies, as well as identify, license or
acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.


